ACR urged to accelerate efforts to develop quality indicators
Birthday in Bean Town
As TR celebrates one year, we look forward to an exciting 2008
Enhanced Opportunities at the 2007 Meeting
The AMPC is using more translational components as a way of increasing the basic scientist’s interaction with clinicians, he explains. In keeping with this, the meeting will offer sessions on osteoclasts, implications for the development and treatment of osteoarthritis, T-cell subsets, and a year in review – all of which will be of interest to both the clinician and the basic researcher.
Abstracts Highlight Latest Scientific Advances
The ACR has accepted 2,034 abstracts and the ARHP has accepted 92 abstracts for presentation during this year’s annual meeting. These abstracts will be presented in more than 50 concurrent sessions and three poster sessions.
Art and Medicine Converge for the Klemperer Lecture
Growing up in Brooklyn, N.Y., Paul H. Plotz, MD, often enjoyed an exciting game of stoopball with friends. Young Plotz took turns beaming a ball at the corner of his stoop, stopping occasionally to allow his father’s patients to enter the front door of his house, which also doubled as his father’s office.
Clinical Cutting Edge
Updates on Sjogren’s syndrome, myositis, and vasculitis
ACR Meeting: 1975 to Now
We’ve has come a long way, but 2007 holds more growth
Minimally Invasive Total Hip Arthroplasty Audioconference
Want to learn more about total hip arthroplasty? Register for the January 17 ARHP Rheumatology Audioconference, Minimally Invasive and Percutaneous Total Hip Arthroplasties, where Alberto Bolanos, MD, will describe the latest advances in these procedures.
2007 Recertification Opportunities from ACR
The ACR has several opportunities for rheumatologists who must recertify through the American Board of Internal Medicine (ABIM).
Innovative Therapies in Autoimmune Diseases
The Innovative Therapies in Autoimmune Diseases Conference will be held at the Westin Arlington Gateway in Arlington, Va. March 2–4, 2007. The conference brings together researchers, Food and Drug Administration representatives, and pharmaceutical representatives in a unique forum to discuss new therapies in rheumatology.